Calcium phosphate product in hemodialysis patients in Marjan Teaching Hospital

Abstract EN

Background: Chronic renal failure is a growing field in medicine with multisystem complications.

Calcium and phosphate are among the major metabolic disturbances that affect all systems and mainly the vascular body components and mainly the coronary circulation.

Objectives: The aim of the study is to identify the weight of control and distribution of the calcium phospahate product among our unit hemodialysis patients.

Patients and method : This is a cross section study enrolling 47 hemodialysis end stage renal disease in Merjan hemodialysis unit .

investigations implicated in the study are those who were routinely done for the follow up the units patients.

Biotek kits were used in the biochemistry measures.

Results: There were significant mean differences of Ca2+ Po4+ Product grades by age, serum creatinine and Po4+.

Patients with severe Ca2+ Po4+ Product aged 32 years.

Meanwhile, patients with severe Ca2+ Po4+ Product had serum creatinine more than 11mg/dl.

Furthermore, patients with severe Ca2+ Po4+ Product had Po4+ more than 10 mg/dl.

Conclusions: Calcium x phosphate product is high in many of our patient on hemodialysis and thus many of them are in the elevated rank of increased cardiovascular mortality Recommendations 1.

More diet control 2.

More frequent hemodialysis sessions are required and longer duration of hemodialysis 3.

.parathyroid hormone level must be checked frequently.